{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:53:53Z","timestamp":1761238433992},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2 and 3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4]]},"abstract":"<jats:p>Despite greater chronic pain prevalence in females compared with males, and the analgesic potential of cannabinoid receptor type 2 (CB2) agonists, CB2 agonists have rarely been tested in females. The aim of the present study was to compare the antinociceptive effects of a CB2-preferring agonist, (2-methyl-1-propyl-1H-indol-3-yl)-1-naphthalenylmethanone (JWH015), in female and male rats against acute pain and persistent inflammatory pain. JWH015 (5\u201320\u2009mg\/kg, intraperitoneally) produced dose-dependent and time-dependent increases in latency to respond on the tail withdrawal and paw pressure tests that did not differ statistically between the sexes. JWH015 dose-dependently decreased locomotor activity in both sexes, but was more potent in females than males. JWH015 produced little catalepsy in either sex. In females, the antinociceptive effects of JWH015 against acute pain were blocked by rimonabant and SR144528, whereas locomotor suppression was antagonized by rimonabant. When administered 3 days after intraplantar injection of complete Freund\u2019s adjuvant, JWH015 produced a significantly greater antiallodynic effect in females at the highest dose tested (10\u2009mg\/kg, intraperitoneally). Antiallodynic effects of JWH015 were antagonized by rimonabant and SR144528 in both sexes. These studies indicate that systemically administered JWH015 produced antinociception that was both CB1 and CB2 receptor-mediated in both sexes. Unlike \u2206-9-tetrahydrocannabinol and other nonselective cannabinoid agonists, the CB2-preferring agonist JWH015 may produce more equivalent antinociception in females and males.<\/jats:p>","DOI":"10.1097\/fbp.0000000000000337","type":"journal-article","created":{"date-parts":[[2017,9,13]],"date-time":"2017-09-13T23:50:11Z","timestamp":1505346611000},"page":"280-289","source":"Crossref","is-referenced-by-count":10,"title":["Antinociceptive effects of JWH015 in female and male rats"],"prefix":"10.1097","volume":"29","author":[{"given":"Rebecca M.","family":"Craft","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas Z.","family":"Greene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexa A.","family":"Wakley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230910","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejphar.2004.10.043","article-title":"\u22069-Tetrahydrocannabinol-induced conditioned place preference and intracerebroventricular self-administration in rats","volume":"506","author":"Braida","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"R2-20230910","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.2174\/13816128113199990430","article-title":"Male and female rats differ in brain cannabinoid CB1 receptor density and function and in behavioural traits predisposing to drug addiction: effect of ovarian hormones","volume":"20","author":"Castelli","year":"2014","journal-title":"Curr Pharm Des"},{"key":"R3-20230910","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugalcdep.2016.08.001","article-title":"Sex-dependent effects of cannabis-induced analgesia","volume":"167","author":"Cooper","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"R4-20230910","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1038\/npp.2013.97","article-title":"Comparison of the analgesic effects of dronabinol and smoked marijuana in daily marijuana smokers","volume":"38","author":"Cooper","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"R5-20230910","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1037\/a0012931","article-title":"Sex differences in analgesic, reinforcing, discriminative, and motoric effects of opioids","volume":"16","author":"Craft","year":"2008","journal-title":"Exp Clin Psychopharmacol"},{"key":"R6-20230910","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1124\/jpet.111.188540","article-title":"Sex differences in CB1 vs. CB2 receptor-selective antagonism of antinociception produced by delta-9-THC and CP55,490 in the rat","volume":"340","author":"Craft","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"R7-20230910","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.pain.2013.05.017","article-title":"Sex differences in anti-allodynic, anti-hyperalgesic and anti-edema effects of \u0394(9)-tetrahydrocannabinol in the rat","volume":"154","author":"Craft","year":"2013","journal-title":"Pain"},{"key":"R8-20230910","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ejps.2004.07.013","article-title":"Comparison of cannabinoid ligands affinities and efficacies in murine tissues and in transfected cells expressing human recombinant cannabinoid receptors","volume":"23","author":"Govaerts","year":"2004","journal-title":"Eur J Pharm Sci"},{"key":"R9-20230910","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1213\/ANE.0b013e31821d1062","article-title":"Intrathecal administration of the cannabinoid 2 receptor agonist JWH015 can attenuate cancer pain and decrease mRNA expression of the 2B subunit of N-methyl-d-aspartic acid","volume":"113","author":"Gu","year":"2011","journal-title":"Anesth Analg"},{"key":"R10-20230910","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.bjp.0707531","article-title":"A therapeutic target for the treatment of inflammatory and neuropathic pain","volume":"153","author":"Guindon","year":"2008","journal-title":"Br J Pharmacol"},{"key":"R11-20230910","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1476-5381.2010.01046.x","article-title":"Central and peripheral sites of action for CB2 receptor mediated analgesic activity in chronic inflammatory and neuropathic pain models in rats","volume":"162","author":"Hsieh","year":"2011","journal-title":"Br J Pharmacol"},{"key":"R12-20230910","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.bmc.2004.09.050","article-title":"Structure-activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB1 and CB2 receptors: steric and electronic effects of naphthoyl substitutes. New highly selective CB2 receptor agonists","volume":"13","author":"Huffman","year":"2005","journal-title":"Bioorg Med Chem"},{"key":"R13-20230910","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.pain.2005.12.018","article-title":"CB2 cannabinoid receptor mediation of antinociception","volume":"122","author":"Ibrahim","year":"2006","journal-title":"Pain"},{"key":"R14-20230910","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/FBP.0b013e3282f00c10","article-title":"Influence of nicotinic receptor modulators on CB2 cannabinoid receptor agonist (JWH133)-induced antinociception in mice","volume":"18","author":"Jafari","year":"2007","journal-title":"Behav Pharmacol"},{"key":"R15-20230910","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.jpain.2012.05.013","article-title":"Spinal cannabinoid receptor type 2 agonist reduces mechanical allodynia and induces mitogen-activated protein kinase phosphatases in a rat model of neuropathic pain","volume":"13","author":"Landry","year":"2012","journal-title":"J Pain"},{"key":"R16-20230910","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1365-2125.2011.03970.x","article-title":"Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials","volume":"72","author":"Lynch","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"R17-20230910","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11481-015-9600-6","article-title":"Cannabinoids for the treatment of chronic non-cancer pain: an updated systematic review of randomized controlled trials","volume":"10","author":"Lynch","year":"2015","journal-title":"J Neuroimmune Pharmacol"},{"key":"R18-20230910","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S1471-4892(02)00004-8","article-title":"CB2 cannabinoid receptor agonists: pain relief without psychoactive effects?","volume":"3","author":"Malan","year":"2003","journal-title":"Curr Opin Pharmacol"},{"key":"R19-20230910","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.phrs.2012.08.002","article-title":"The CB2-preferring agonist JWH015 also potently and efficaciously activates CB1 in autaptic hippocampal neurons","volume":"66","author":"Murataeva","year":"2012","journal-title":"Pharmacol Res"},{"key":"R21-20230910","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1016\/j.pain.2012.07.037","article-title":"Effects of gonadal hormones on the peripheral cannabinoid receptor 1 (CB1R) system under a myositis condition in rats","volume":"153","author":"Niu","year":"2012","journal-title":"Pain"},{"key":"R22-20230910","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1369-1600.2008.00108.x","article-title":"Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond","volume":"13","author":"Pertwee","year":"2008","journal-title":"Addict Biol"},{"key":"R23-20230910","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1185\/030079908X280635","article-title":"Analgesic and antihyperalgesic effects of nabilone on experimental heat pain","volume":"24","author":"Redmond","year":"2008","journal-title":"Curr Med Res Opinion"},{"key":"R24-20230910","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0024-3205(94)00585-0","article-title":"Cannabinoid receptors in rat brain areas: sexual differences, fluctuations during estrous cycle and changes after gonadectomy and sex steroid replacement","volume":"54","author":"Rodriguez de Fonseca","year":"1994","journal-title":"Life Sci"},{"key":"R25-20230910","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0165-3806(02)00306-1","article-title":"Antinociceptive, behavioural and neuroendocrine effects of CP 55,940 in young rats","volume":"136","author":"Romero","year":"2002","journal-title":"Brain Res Dev Brain Res"},{"key":"R26-20230910","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/01.anes.0000264765.33673.6c","article-title":"Spinal cannabinoid receptor type 2 activation reduces hypersensitivity and spinal cord glial activation after paw incision","volume":"106","author":"Romero-Sandoval","year":"2007","journal-title":"Anesthesiology"},{"key":"R27-20230910","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/ALN.0b013e318167af74","article-title":"Spinal microglial and perivascular cell cannabinoid receptor type 2 activation reduces behavioral hypersensitivity without tolerance after peripheral nerve injury","volume":"108","author":"Romero-Sandoval","year":"2008","journal-title":"Anesthesiology"},{"key":"R28-20230910","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0014-2999(01)01267-5","article-title":"Sex differences in antinociceptive and motoric effects of cannabinoids","volume":"430","author":"Tseng","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"R29-20230910","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0306-4522(97)00436-3","article-title":"Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system","volume":"83","author":"Tsou","year":"1998","journal-title":"Neurosci"},{"key":"R30-20230910","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0304-3959(95)00214-6","article-title":"Gender variations in clinical pain experience","volume":"65","author":"Unruh","year":"1996","journal-title":"Pain"},{"key":"R31-20230910","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.pbb.2014.06.007","article-title":"Cyclic ovarian hormone modulation of supraspinal \u03949-tetrahydrocannabinol-induced antinociception and cannabinoid receptor binding in the female rat","volume":"124","author":"Wakley","year":"2014a","journal-title":"Pharmacol Biochem Behav"},{"key":"R32-20230910","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.drugalcdep.2014.07.029","article-title":"Sex differences in antinociceptive tolerance to delta-9-tetrahydrocannabinol in the rat","volume":"143","author":"Wakley","year":"2014b","journal-title":"Drug Alcohol Depend"},{"key":"R33-20230910","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0163-7258(02)00252-8","article-title":"Cannabinoid analgesia","volume":"95","author":"Walker","year":"2002","journal-title":"Pharmacol Ther"},{"key":"R34-20230910","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.jpain.2015.07.014","article-title":"Cannabis for the management of pain: Assessment of safety study (COMPASS)","volume":"16","author":"Ware","year":"2015","journal-title":"J Pain"},{"key":"R35-20230910","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neulet.2011.05.013","article-title":"Cannabinoid receptor expression and phosphorylation are differentially regulated between male and female cerebellum and brain stem after repeated stress: implication for PTSD and drug abuse","volume":"502","author":"Xing","year":"2011","journal-title":"Neurosci Lett"},{"key":"R36-20230910","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.1523\/JNEUROSCI.3554-05.2006","article-title":"Two brain sites for cannabinoid reward","volume":"26","author":"Zangen","year":"2006","journal-title":"J Neurosci"},{"key":"R37-20230910","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1046\/j.1460-9568.2003.02704.x","article-title":"Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models","volume":"17","author":"Zhang","year":"2003","journal-title":"Eur J Neurosci"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00008877-201804000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T08:13:43Z","timestamp":1694333623000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008877-201804000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":36,"journal-issue":{"issue":"2 and 3","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0000000000000337","relation":{},"ISSN":["0955-8810"],"issn-type":[{"value":"0955-8810","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]}}}